Clinical trial
Substrate Modification in Stable Ventricular Tachycardia in Addition to ICD Therapy
NCT00919373 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Substrate Modification in Stable Ventricular Tachycardia in Addition to ICD Therapy
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- January 31, 2006
- Enrollment
- 110 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, left ventricular dysfunction, ventricular tachycardia